We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pipeline Setbacks for Big Pharma: AZ, Sanofi, Novartis, GSK Take Hits
Pipeline Setbacks for Big Pharma: AZ, Sanofi, Novartis, GSK Take Hits
January 4, 2012
Big Pharma saw several pipeline setbacks in December, with AstraZeneca, Sanofi, Novartis and GlaxoSmithKline (GSK) announcing trial failures, a study termination and the end of a drug development program.